Acrivon Therapeutics (ACRV) Other Accumulated Expenses (2021 - 2026)
Acrivon Therapeutics' Other Accumulated Expenses was $4.77 million in Q2 2026, down 30.3% from $6.84 million a year earlier and down 14.0% from the prior quarter.
Powered by 
Analysis
Acrivon Therapeutics (ACRV) Other Accumulated Expenses (2021 - 2026) Analysis & Trends
At the end of FY2025, Other Accumulated Expenses at Acrivon Therapeutics came in at $5.96 million, down 35.5% from FY2024.
- Other Accumulated Expenses shows a four-year compound annual growth rate of 95.5% (FY2021 to FY2025).
- In earlier years, Other Accumulated Expenses was $9.25 million in FY2024 (+247.5%), $2.66 million in FY2023 (+236.8%), $790,000 in FY2022 (+93.6%) and $408,000 in FY2021.
- The Q2 2026 figure marks the lowest quarterly Other Accumulated Expenses since Q1 2024.
- Compared with a year earlier, Other Accumulated Expenses has declined for three straight quarters, with growth averaging 55.2% over the last eight quarters.
- The best year-over-year quarter for Other Accumulated Expenses over five years was Q4 2024 (growth of 247.5%); the worst was Q4 2025 (a decline of 35.5%).
- Per Business Quant data, ACRV's Other Accumulated Expenses in the three quarters before Q2 2026 was $5.54 million (Q1 2026), $5.96 million (Q4 2025) and $7.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Acrivon Therapeutics | 85.27 Mn | 85.27 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 4.77 Mn |
| Mar 31, 2026 | 5.54 Mn |
| Dec 31, 2025 | 5.96 Mn |
| Sep 30, 2025 | 7.88 Mn |
| Jun 30, 2025 | 6.84 Mn |
| Mar 31, 2025 | 5.58 Mn |
| Dec 31, 2024 | 9.25 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 5.07 Mn |
| Mar 31, 2024 | 3.42 Mn |
| Dec 31, 2023 | 2.66 Mn |
| Sep 30, 2023 | 2.92 Mn |
| Jun 30, 2023 | 2.05 Mn |
| Mar 31, 2023 | 1.41 Mn |
| Dec 31, 2022 | 790,000.00 |
| Sep 30, 2022 | 1.10 Mn |
| Dec 31, 2021 | 408,000.00 |
API Access
Acrivon Therapeutics Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACRV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "ACRV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=ACRV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();